Discover 3,553 paid clinical trials in Glendale, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,553
Active & ResponsiveNew
Effects of Dietary Supplements on Muscle Mass and Function While Using GLP-1 Medication
for
Obesity & Overweight, Muscle Mass and Strength, Muscle Function
Location: Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: All
Age: 18+
Code: NCT07806838
Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
for
Triple Negative Breast Neoplasms
Location: Los Angeles CA, Duarte CA, Irvine CA, Las Vegas NV,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06841354
Phase3, Recruiting
Active & Responsive
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Los Angeles CA, Stanford CA, Houston TX, Detroit MI,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT07111520
Phase1, Phase2, Recruiting
Active & Responsive
Study of DISC-0974-201 in Participants With IBD and Anemia
for
Inflammatory Bowel Disease (IBD), Anemia,
Location: Los Angeles CA, Scottsdale AZ, Kingwood TX,
Location: Los Angeles CA, Sacramento CA, Salt Lake City UT,
Sponsor: Abbott Medical Devices
Sex: All
Age: 22 - 70
Code: NCT06423430
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
for
Alpha1-Antitrypsin Deficiency
Location: Los Angeles CA, La Jolla CA, Palo Alto CA,
Sponsor: Takeda
Sex: All
Age: 18 - 70+
Code: NCT05677971
Phase3, Recruiting
Active & Responsive
Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study
for
Friedreich Ataxia
Location: Los Angeles CA, Denver CO, Iowa City IA, Memphis TN,
Sponsor: Friedreich's Ataxia Research Alliance
Sex: All
Age: 0+
Code: NCT06016946
Recruiting
Active & Responsive
Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode
for
Schizophrenia, Schizophreniform Disorder,
Location: Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: All
Age: 18 - 45
Code: NCT05890183
Recruiting
Active & Responsive
NIRS for the Diagnosis of Myofascial Pelvic Pain
for
Myofascial Pelvic Pain
Location: Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: Female
Age: 18+
Code: NCT07181447
Recruiting
Active & Responsive
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
for
Myasthenia Gravis, Generalized Myasthenia Gravis
Location: Los Angeles CA, Orange CA, Palo Alto CA, Murray UT,
Sponsor: Kyverna Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06193889
Phase2, Phase3, Recruiting
Active & Responsive
A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients
for
Breast Cancer Screening, Artificial Intelligence (AI)
Location: Los Angeles CA, San Diego CA, Seattle WA, Madison WI,
Sponsor: Jonsson Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT06934239
Recruiting
Active & Responsive
A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants, Adolescents and Adults With Hearing Loss Due to Otoferlin Mutations
for
Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF),
Location: Los Angeles CA, San Diego CA, Seattle WA, Milwaukee WI,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 0+
Code: NCT05788536
Phase1, Phase2, Recruiting
Active & Responsive
Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients